Simplex Trading, LLC Crispr Therapeutics Ag Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Simplex Trading, LLC holds 66,880 shares of CRSP stock, worth $2.96 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

66,880

Holding current value

$2.96 Million

% of portfolio

0.11%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$44.62 - $62.75 $2.98 Million - $4.2 Million	66,880 New	66,880 $3.14 Million
Q3 2023 Nov 01, 2023	BUY	$45.39 - $59.0 $1.47 Million - $1.91 Million	32,454 Added 1386.92%	34,794 $1.58 Million
Q2 2023 Aug 04, 2023	SELL	$43.47 - $67.77 $584,106 - $910,625	-13,437 Reduced 85.17%	2,340 $131,000
Q1 2023 Apr 27, 2023	BUY	$41.0 - $56.12 $406,679 - $556,654	9,919 Added 169.32%	15,777 $713,000
Q4 2022 Feb 02, 2023	BUY	$39.19 - $65.67 $137,870 - $231,027	3,518 Added 150.34%	5,858 $238,000
Q2 2022 Aug 03, 2022	SELL	$43.23 - $73.83 $618,102 - $1.06 Million	-14,298 Reduced 85.94%	2,340 $142,000
Q1 2022 May 02, 2022	BUY	$53.19 - $79.24 $171,112 - $254,915	3,217 Added 23.97%	16,638 $1.04 Million
Q4 2021 Feb 23, 2022	SELL	$70.09 - $111.29 $123,708 - $196,426	-1,765 Reduced 11.62%	13,421 $1.02 Million
Q3 2021 Oct 28, 2021	BUY	$110.2 - $156.64 $45,402 - $64,535	412 Added 2.79%	15,186 $2.38 Million
Q2 2021 Aug 12, 2021	BUY	$100.84 - $161.89 $1.29 Million - $2.07 Million	12,794 Added 646.16%	14,774 $2.39 Million
Q1 2021 Apr 26, 2021	SELL	$110.72 - $210.04 $1.32 Million - $2.51 Million	-11,953 Reduced 85.79%	1,980 $241,000
Q4 2020 Feb 02, 2021	BUY	$79.67 - $173.23 $1.11 Million - $2.41 Million	13,933 New	13,933 $2.13 Million
Q3 2020 Oct 14, 2020	SELL	$78.5 - $100.64 $398,937 - $511,452	-5,082 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$38.5 - $76.05 $192,153 - $379,565	4,991 Added 5484.62%	5,082 $373,000
Q1 2020 Apr 29, 2020	BUY	$33.68 - $62.53 $3,064 - $5,690	91 New	91 $3,000
Q2 2018 Jul 30, 2018	SELL	$42.62 - $73.59 $853,039 - $1.47 Million	-20,015 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$23.52 - $58.17 $405,649 - $1 Million	17,247 Added 623.09%	20,015 $914,000
Q4 2017 Jan 10, 2018	SELL	$16.95 - $23.48 $9,407 - $13,031	-555 Reduced 16.7%	2,768 $64,000
Q3 2017 Oct 25, 2017	BUY	$16.75 - $20.66 $55,660 - $68,653	3,323	3,323 $59,000

Others Institutions Holding CRSP

# of Institutions

485

Shares Held

57.9M

Call Options Held

1.09M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.45B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Crispr Therapeutics Ag Transaction History